论文部分内容阅读
免疫系统的新生物是一组杂合性肿瘤,细胞可能源出淋巴细胞、组织细胞或免疫系统的其它细胞成分。据认为,每个肿瘤都是癌细胞,单克隆扩张,但此说还只在淋巴细胞肿瘤中得到确切证明。令人注意的是:这些肿瘤往往还保留其正常细胞常有的形态、功能和移动等特性。随着对正常免疫系统认识的深入,现在已有可能按细胞来源对恶性免疫疾患进行分类。表157-1就是按现有免疫学观点提出的肿瘤名录。B淋巴细胞系列肿瘤是以荧光抗免疫球蛋白抗体检查细胞表面免疫球蛋白而确定的。每一B淋巴细胞新生物都能按其重链和轻链类别进行免疫分型,并能证实其为一单克隆病变过程。这种免疫学表型可以把病
The neoplasia of the immune system is a group of heterozygous tumors, and cells may elicit lymphocytes, tissue cells, or other cellular components of the immune system. It is thought that each tumor is a cancerous cell with a monoclonal expansion, but this is only confirmed in lymphoid tumors. It is noteworthy that these tumors often retain their normal cell morphology, function and movement characteristics. With the deepening of understanding of the normal immune system, it has now been possible to classify malignant immune disorders by cell source. Table 157-1 is based on the existing immunology point out the list of tumors. B lymphocyte series tumor is based on fluorescent anti-immunoglobulin antibody to detect cell surface immunoglobulin and determine. Each B lymphocyte neoplasm can be immunotyped by its heavy and light chain class and confirmed as a monoclonal pathology. This immunological phenotype can put the disease